BWX Technologies, Inc. Q2 FY26 Earnings Analysis

- BWXT expects overall 2026 revenue of at least $3.75 billion, up high teens compared to 2025. - Government Operations projected low teens growth, driven largely by defense fuels and HPDU contracts. - Commercial Operations expected to grow approximately 30% revenue, fueled by low teens growth in commercial power, high teens in medical, and a full year contribution from Kinectrics. - The acquisition of PCG supports growth with anticipated mid-single digits revenue growth in 2026 (excluded from current guidance). - Backlog increased 77% year-over-year to $8.7 billion, providing strong visibility to future growth. - Demand for commercial nuclear power components is accelerating in the U.S., Canada, and Europe, indicating continued volume increases. - Expansion of U.S. commercial manufacturing capacity (e.g., PCG acquisition and potential greenfield plant) aims to capture this rising demand and enable scalable growth.

- Full-year 2026 revenue expected to be at least $3.75 billion, up high teens from 2025. - Adjusted EBITDA guidance increased by $5 million on each end to a range of $650 million to $665 million. - Non-GAAP earnings per share guidance raised to $4.60 to $4.75, driven by higher operating earnings. - Full-year operating earnings expected to be slightly back half weighted, with about 55% of EBITDA in the second half. - Second quarter EBITDA expected to be roughly in line with or slightly below first quarter levels. - Free cash flow guidance set at $315 million to $330 million, indicating mid- to high-teens growth in operating cash flow. - Growth driven by strong commercial nuclear and medical segments plus government contracts. - Acquisition of PCG will contribute to growth but is not included in 2026 guidance as it closes in second half.

- Current CapEx for 2026 expected around 6% of sales; Q1 CapEx was $43 million. - Potential for CapEx to exceed 6% in future due to growth investments in U.S. commercial nuclear manufacturing capacity and advanced nuclear/fuel capabilities. - Considering greenfield facility near Mount Vernon for large-scale component manufacturing, potentially doubling the Cambridge plant expansion scale (~100,000 sq ft). - Expansion includes 60,000 sq ft brownfield expansion at Cambridge plant underway. - Strategic investments balanced with financial return metrics; aim to avoid high past CapEx levels (9-10%). - PCG acquisition (~$200 million) adds manufacturing capacity and workforce; primarily focused on manufacturing certain components but limited for very large/heavy components. - Focus on increasing throughput (operational excellence initiatives) alongside adding physical capacity. - Build-out supported by strong demand and backlog, including government and commercial sectors.

- There is no explicit mention of current or planned fundraising through debt or equity in the provided transcript. - Rex Geveden states that BWXT has the balance sheet strength to fund capacity expansion internally ("we have got the balance sheet to do what we need to do in terms of capacity"). - Capital expenditures may exceed typical levels as BWXT advances growth investments, but these are being carefully balanced against financial return metrics. - No announcements or discussions of issuing new debt or equity to fund operations, acquisitions, or growth initiatives are noted. - Acquisition of PCG (~$200 million) is expected to close with no indication of raising external capital. - Overall, BWXT appears to be funding growth and capacity expansions through existing financial resources without immediate plans for new fundraising via debt or equity.

- Government Operations backlog nearly $7 billion, up 25% sequentially and 93% year-over-year. - Strong bookings include $1.4 billion from the Naval reactors pricing agreement awarded last year. - Commercial Operations backlog flat sequentially in Q1 but up 33% year-over-year after an 85% increase in 2025. - Robust order flow expected from ongoing and upcoming nuclear projects, including SMRs like the GE Hitachi BWRX-300. - Kinectrics acquisition contributes to backlog growth with new contracts, e.g., UK Tritium loop facility design and fabrication. - PCG acquisition (~$125 million revenue) expected to close in H2 2026, but contributions not included in current guidance. - Early work underway for next Ford-class and Columbia-class ship sets under naval propulsion contracts. - Significant long lead material procurement contracts support out-year production.